Sterling Bay Signs Four Biotech Tenants at Life Sciences Hub
Sterling Bay has signed four new biotech tenants at 2430 N. Halsted, a recently revamped scientific research facility in Chicago’s Lincoln Park. Seq Biomarque, a research and diagnostic technologies firm, works to develop highly sensitive blood-based multi-factor screening and diagnostic tests for Alzheimer’s disease. CeGaT Corporationis making its debut in the U.S., and the company focuses on advancements in genomics and personalized medicine.
Spun out of the University of Michigan’s on-campus lab, EVOQ Therapeutics works to reform autoimmune disease treatment with novel immunotherapies. Cyclopure specializes in water purification and water treatment technologies and is relocating to the hub from the Illinois Science + Technology Park.
Dave Gloor and Daniella Hemsley negotiated the transactions on behalf of Sterling Bay. Jonathan Metzl and Jack Deroche of Cushman & Wakefield represented Cyclopure. Sterling Bay’s life sciences hub creates adaptable lab spaces for biotech firms at different growth stages, and the property’s flexible options support startups’ evolving needs as they scale.
“It’s about creating a range of spaces that meet users wherever they’re at in their growth cycle.”
Jasmine Kilman is Content Director of Connect Commercial Real Estate, covering Chicago and greater Chicagoland, the Midwest, Seattle, and the Pacific Northwest. She covers industry trends, transaction deals, market research, and produces daily news stories.
With experience in marketing and communications for academic nonprofits and corporate clients, including Hearst Media, Hilton, and Coldwell Banker, Kilman has written about commercial real estate, environmental, social, and corporate governance (ESG), technology, healthcare, and philanthropy. She was born and raised in California and graduated with a degree in public relations. In her spare time, Kilman enjoys hiking and traveling to new locations with her family.